Event Brief
Jul 20, 2026 at 4:00 AM ET
Samsung Biologics buys Swiss peptide maker for $1.8bn
By The BriefBrief
Samsung Biologics agreed to acquire Swiss peptide maker PolyPeptide for $1.8 billion.
WHO: Samsung Biologics
WHAT: Samsung Biologics agreed to buy Swiss peptide maker PolyPeptide for $1.8 billion
WHEN: Jul 20, 2026 at 2:53 AM ET
WHERE: Switzerland
WHY: Cause not yet established.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Analysts urge US and Iran to draw down escalation
Us
Jul 20, 2026 at 4:03 AM ET
16-Jähriger bei Traktor-Zusammenstoß in Niederbayern schwer verletzt
Niederbayern
Jul 20, 2026 at 4:02 AM ET
Russland meldet Abwehr von mehr als 400 Drohnen
Russland
Jul 20, 2026 at 4:02 AM ET
Brantner: Spahn-Rücktritt eröffnet Chance für Kabinettsumbau
Grüne
Jul 20, 2026 at 4:02 AM ET
Page 12425 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
